LOR-264

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameLOR-264
Drug Alias NameKLF-4-targeting small molecule (Lorus)second generation LOR-253 derivatives (Lorus)LOR-264
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetal regulatory transcription factor 1 inhibitorsKruppel-like factor 4 stimulants
TargetsMetal regulatory transcription factor 1Kruppel-like factor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAptose Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAptose Biosciences Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A